Neurotrope, Inc. (NTRP), a clinical-stage biopharmaceutical company developing novel therapies for neurodegenerative diseases, including Alzheimer’s disease (“AD”), announced today that Michael Ciraolo, J.D., Ph.D., is joining the Company as general counsel and chief operating officer.
April 1, 2019
· 4 min read